Thermon Group Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Employees Common Stock	Executive Officer Common Stock	Director Common Stock
Balance, beginning of period (in shares) at Mar. 31, 2023		33,508,076
Balance, beginning of period at Mar. 31, 2023	$ 418,988	$ 33	$ 239,860		$ 237,195	$ (58,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							73,345	93,826	5,718
Stock compensation expense	1,238		1,238
Repurchase of employee stock units on vesting	(1,685)		(1,685)
Net income	10,938				10,938
Foreign currency translation adjustment	4,457					4,457
Other	13					13
Balance, end of period (in shares) at Jun. 30, 2023		33,680,965
Balance, end of period at Jun. 30, 2023	433,949	$ 33	239,413		248,133	(53,630)
Balance, beginning of period (in shares) at Mar. 31, 2023		33,508,076
Balance, beginning of period at Mar. 31, 2023	418,988	$ 33	239,860		237,195	(58,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	41,505
Foreign currency translation adjustment	4,684
Balance, end of period (in shares) at Dec. 31, 2023		33,711,599
Balance, end of period at Dec. 31, 2023	467,425	$ 34	242,111		278,701	(53,421)
Balance, beginning of period (in shares) at Jun. 30, 2023		33,680,965
Balance, beginning of period at Jun. 30, 2023	433,949	$ 33	239,413		248,133	(53,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							2,550		7,197
Stock compensation expense	1,450		1,450
Repurchase of employee stock units on vesting	(30)		(30)
Net income	14,730				14,730
Foreign currency translation adjustment	(7,845)					(7,845)
Other	52	$ 1				51
Balance, end of period (in shares) at Sep. 30, 2023		33,690,712
Balance, end of period at Sep. 30, 2023	442,306	$ 34	240,833		262,863	(61,424)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							14,839		6,048
Stock compensation expense	1,444		1,444
Repurchase of employee stock units on vesting	(165)		(165)
Net income	15,837				15,837
Foreign currency translation adjustment	8,072					8,072
Other	(69)		1		1	(69)
Balance, end of period (in shares) at Dec. 31, 2023		33,711,599
Balance, end of period at Dec. 31, 2023	$ 467,425	$ 34	242,111		278,701	(53,421)
Balance, beginning of period (in shares) at Mar. 31, 2024	33,722,225	33,722,225
Balance, beginning of period at Mar. 31, 2024	$ 474,887	$ 34	243,555	$ (250)	288,783	(57,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							56,614	87,782	7,241
Stock compensation expense	1,065		1,065
Repurchase of employee stock units on vesting	(2,995)		(2,995)
Repurchase of shares under authorized program (in shares)		(49,341)
Repurchase of shares under authorized program	(1,579)			(1,579)
Net income	8,511				8,511
Foreign currency translation adjustment	(3,879)					(3,879)
Other	(30)		1			(31)
Balance, end of period (in shares) at Jun. 30, 2024		33,824,521
Balance, end of period at Jun. 30, 2024	$ 475,980	$ 34	241,626	(1,829)	297,294	(61,145)
Balance, beginning of period (in shares) at Mar. 31, 2024	33,722,225	33,722,225
Balance, beginning of period at Mar. 31, 2024	$ 474,887	$ 34	243,555	(250)	288,783	(57,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	36,544
Foreign currency translation adjustment	$ (18,291)
Balance, end of period (in shares) at Dec. 31, 2024	33,708,475	33,708,025
Balance, end of period at Dec. 31, 2024	$ 488,685	$ 34	245,211	(6,440)	325,328	(75,448)
Balance, beginning of period (in shares) at Jun. 30, 2024		33,824,521
Balance, beginning of period at Jun. 30, 2024	475,980	$ 34	241,626	(1,829)	297,294	(61,145)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							924		5,586
Stock compensation expense	1,511		1,511
Repurchase of employee stock units on vesting	(18)		(18)
Repurchase of shares under authorized program (in shares)		(75,752)
Repurchase of shares under authorized program	(2,260)			(2,260)
Net income	9,494				9,494
Foreign currency translation adjustment	5,587					5,587
Other	(7)					(7)
Balance, end of period (in shares) at Sep. 30, 2024		33,755,279
Balance, end of period at Sep. 30, 2024	490,287	$ 34	243,119	(4,089)	306,788	(55,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in exercise of stock option (in shares)		33,573
Issuance of common stock in exercise of stock options	632		632
Issuance of restricted stock as deferred compensation to employees, executive officers and directors (in shares)							911		4,025
Stock compensation expense	1,470		1,470
Repurchase of employee stock units on vesting	(10)		(10)
Repurchase of shares under authorized program (in shares)		(85,763)
Repurchase of shares under authorized program	(2,351)			(2,351)
Net income	18,539				18,539
Foreign currency translation adjustment	(19,999)					(19,999)
Other	$ 117					116
Balance, end of period (in shares) at Dec. 31, 2024	33,708,475	33,708,025
Balance, end of period at Dec. 31, 2024	$ 488,685	$ 34	$ 245,211	$ (6,440)	$ 325,328	$ (75,448)